Outcomes After Lung Transplantation in Patients With Chronic Hepatitis C Virus Infection

Journal of Heart and Lung Transplantation

Volumn 26, Issue 5, 2007, Pages 466-471

  Sahi, Hina ^a   Zein, Nizar N ^a   Mehta, Atul C ^a   Blazey, Holli C ^a   Meyer, Kathryn H ^a   Budev, Marie ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; VIRUS RNA;

ACUTE GRAFT REJECTION; ACUTE HEPATITIS; ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; DEATH; DEMOGRAPHY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; CAUSE OF DEATH; COHORT STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C, CHRONIC; HUMANS; LIVER FUNCTION TESTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 34247177914     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.01.037     Document Type: Article

References (22)

1. Alter M.J., and Mast E.E. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin N Am 23 (1994) 437-455
2. Pol S., Samuel D., Cadranel J., et al. Hepatitis and solid organ transplantation. Transplant Proc 32 (2000) 454-457
3. Therret E., Pol S., Legendre C., et al. Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study. Transplantation 58 (1994) 625-628
4. Rostaing L., Izopet J., Baron E., et al. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 59 (1995) 1426-1431
5. Periera B.J., Wright T.L., Schmid C.H., et al. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 60 (1995) 799-805
6. Pol S., Garrigue V., and Legendre C. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 335 (1996) 522
7. Bouthot B.A., Murthy B.V., Schmid C.H., et al. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement. Transplantation 63 (1997) 849-853
8. Castella M., Tenderich G., Koerner M.M., et al. Outcome of heart transplantation in patients previously infected with hepatitis C virus. J Heart Lung Transplant 20 (2001) 595-598
9. Lake K.D., Smith C.I., Milfred-La Forest S.K., et al. Outcomes of hepatitis C positive (HCV+) heart transplant recipients. Transplant Proc 29 (1997) 581-582
10. Haji S.A., Starling R.C., Avery R.K., et al. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant 23 (2004) 277-283
11. Levine S.M., and Transplant/Immunology Network of the American College of Chest Physicians. A survey of clinical practice of lung transplantation in North America. Chest 125 (2004) 1224-1238
12. Cotler S.J., Jensen D.M., and Kesten S. Hepatitis C virus infection and lung transplantation: a survey of practices. J Heart Lung Transplant 18 (1999) 456-459
13. Carreno M.C., Piedad U.G., Maite L., et al. Hepatitis C virus infection after lung transplantation: dim prognosis. J Heart Lung Transplant 20 (2001) 224
14. Feray C., Gigou M., Samuel D., et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 108 (1995) 1088-1096
15. Feray C., Caccamo L., Alexander G.J., et al., European Concerted Action on Viral Hepatitis (EUROHEP) Group. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Gastroenterology 117 (1999) 615-619
16. Gordon F.D., Poterucha J.J., Germer J., et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 63 (1997) 1419-1423
17. Charlton M., Seaberg E., Wiesner R., et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 28 (1998) 823-830
18. Vargas H.E., Laskus T., Wang L.F., et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transplant Surg 4 (1998) 22-27
19. Zhou S., Terrault N.A., Ferrell L., et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 24 (1996) 1041-1046
20. Gane E.J., Naoumov N.V., Qian K.P., et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 110 (1996) 167-177
21. Chazouilleres O., Kim M., Combs C., et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 106 (1994) 994-999
22. Freeman R.B., Tran S., Lee Y.M., et al. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation 61 (1996) 542-546